X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (105) 105
index medicus (98) 98
male (56) 56
female (54) 54
aged (45) 45
hematology (44) 44
multiple myeloma (42) 42
middle aged (41) 41
multiple myeloma - drug therapy (37) 37
oncology (37) 37
bortezomib (36) 36
adult (33) 33
treatment outcome (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
aged, 80 and over (22) 22
cancer (21) 21
lenalidomide (20) 20
disease-free survival (19) 19
thalidomide - administration & dosage (19) 19
survival (18) 18
thalidomide (18) 18
analysis (17) 17
stem-cell transplantation (17) 17
thalidomide - analogs & derivatives (17) 17
therapy (17) 17
elderly-patients (16) 16
multiple myeloma - mortality (16) 16
dexamethasone (15) 15
prognosis (15) 15
abridged index medicus (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
care and treatment (14) 14
expression (14) 14
prednisone - administration & dosage (14) 14
animals (13) 13
chemotherapy (13) 13
melphalan - administration & dosage (13) 13
research (13) 13
antineoplastic agents - therapeutic use (12) 12
cell biology (12) 12
dexamethasone - administration & dosage (12) 12
patients (12) 12
peripheral neuropathy (12) 12
carfilzomib (11) 11
drug therapy (11) 11
hematology, oncology and palliative medicine (11) 11
initial treatment (11) 11
medical research (11) 11
multiple myeloma - pathology (11) 11
thalidomide - adverse effects (11) 11
clinical trials (10) 10
low-dose dexamethasone (10) 10
multiple myeloma - therapy (10) 10
phase-iii (10) 10
prednisone (10) 10
biochemistry & molecular biology (9) 9
bortezomib-melphalan-prednisone (9) 9
clinical trials as topic (9) 9
maintenance (9) 9
melphalan (9) 9
multiple sclerosis (9) 9
proteasome inhibitors (9) 9
review (9) 9
survival rate (9) 9
trial (9) 9
young adult (9) 9
biomarkers (8) 8
boronic acids - administration & dosage (8) 8
combination (8) 8
diagnosed multiple-myeloma (8) 8
glioblastoma (8) 8
health aspects (8) 8
kaplan-meier estimate (8) 8
lenalidomide plus dexamethasone (8) 8
medicine (8) 8
medicine, experimental (8) 8
mice (8) 8
pyrazines - administration & dosage (8) 8
research paper (8) 8
adolescent (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
apoptosis (7) 7
autologous transplantation (7) 7
biology (7) 7
efficacy (7) 7
geriatric assessment (7) 7
melphalan - adverse effects (7) 7
mutation (7) 7
neurosciences (7) 7
open-label (7) 7
oral melphalan (7) 7
research article (7) 7
retrospective studies (7) 7
thalidomide - therapeutic use (7) 7
antineoplastic agents - administration & dosage (6) 6
cell line, tumor (6) 6
combination therapy (6) 6
cyclophosphamide (6) 6
dose-response relationship, drug (6) 6
elderly (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2015, Volume 126, Issue 19, pp. 2179 - 2185
Journal Article
Haematologica, ISSN 0390-6078, 01/2015, Volume 100, Issue 10, pp. 1254 - 1266
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2016, Volume 34, Issue 30, pp. 3600 - 3604
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a... 
SURVIVAL | TRIALS | METAANALYSIS | INTERNATIONAL-SOCIETY | OLDER PATIENTS | ONCOLOGY | RELEVANCE | LENALIDOMIDE | COMPREHENSIVE GERIATRIC ASSESSMENT | REGIMENS | CANCER
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2010, Volume 28, Issue 34, pp. 5101 - 5109
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2014, Volume 32, Issue 7, pp. 634 - 640
Journal Article
CURRENT OPINION IN ONCOLOGY, ISSN 1040-8746, 09/2017, Volume 29, Issue 5, pp. 315 - 321
Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 12/2018, Volume 58, pp. 64 - 69
Multiple myeloma (MM) is a neoplastic disease typical of the elderly. Many steps forward have been made in the characterization of patients, and new treatment... 
SURVIVAL | CRITERIA | MAINTENANCE | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | GERIATRIC ASSESSMENT | OLDER-ADULTS | LENALIDOMIDE PLUS DEXAMETHASONE | INITIAL TREATMENT | PHASE-3 | BORTEZOMIB-MELPHALAN-PREDNISONE | Aged patients | Multiple myeloma
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 36, pp. 60656 - 60672
Journal Article
Journal Article
The Lancet Haematology, ISSN 2352-3026, 03/2019, Volume 6, Issue 3, pp. e117 - e118
Journal Article